Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Inventory: 2023-2025

Historic Inventory for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to $37.6 million.

  • Krystal Biotech's Inventory rose 102.53% to $37.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.6 million, marking a year-over-year increase of 102.53%. This contributed to the annual value of $26.5 million for FY2024, which is 279.50% up from last year.
  • Latest data reveals that Krystal Biotech reported Inventory of $37.6 million as of Q3 2025, which was up 21.23% from $31.0 million recorded in Q2 2025.
  • Krystal Biotech's Inventory's 5-year high stood at $37.6 million during Q3 2025, with a 5-year trough of $5.3 million in Q3 2023.
  • Moreover, its 3-year median value for Inventory was $18.6 million (2024), whereas its average is $19.9 million.
  • Data for Krystal Biotech's Inventory shows a peak YoY soared of 279.50% (in 2024) over the last 5 years.
  • Over the past 3 years, Krystal Biotech's Inventory (Quarterly) stood at $7.0 million in 2023, then spiked by 279.50% to $26.5 million in 2024, then soared by 102.53% to $37.6 million in 2025.
  • Its Inventory was $37.6 million in Q3 2025, compared to $31.0 million in Q2 2025 and $29.9 million in Q1 2025.